Exhibit 2.1
EXECUTION COPY
AGREEMENT AND PLAN OF
MERGER
BY AND AMONG
TRIAD HOSPITALS,
INC.,
COMMUNITY HEALTH SYSTEMS,
INC.
AND
FWCT-1 ACQUISITION
CORPORATION
MARCH 19,
2007
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
ARTICLE I
|
|
DEFINITIONS
|
|
2
|
|
|
|
|
|
Section 1.1
|
|
Definitions
|
|
2
|
|
|
|
|
|
Section 1.2
|
|
Terms Generally
|
|
9
|
|
|
|
|
|
ARTICLE II
|
|
THE
MERGER
|
|
10
|
|
|
|
|
|
Section 2.1
|
|
The Merger
|
|
10
|
|
|
|
|
|
Section 2.2
|
|
Closing
|
|
10
|
|
|
|
|
|
Section 2.3
|
|
Effective Time
|
|
10
|
|
|
|
|
|
Section 2.4
|
|
Effects of the Merger
|
|
10
|
|
|
|
|
|
Section 2.5
|
|
Organizational Documents
|
|
11
|
|
|
|
|
|
Section 2.6
|
|
Directors and Officers of Surviving
Corporation
|
|
11
|
|
|
|
|
|
ARTICLE III
|
|
EFFECT OF THE
MERGER ON THE CAPITAL STOCK OF THE CONSTITUENT
CORPORATIONS
|
|
11
|
|
|
|
|
|
Section 3.1
|
|
Conversion of Securities
|
|
11
|
|
|
|
|
|
Section 3.2
|
|
Payment of Cash for Merger Shares
|
|
12
|
|
|
|
|
|
Section 3.3
|
|
Treatment of Options and Other Awards
|
|
14
|
|
|
|
|
|
ARTICLE IV
|
|
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
|
|
16
|
|
|
|
|
|
Section 4.1
|
|
Corporate Existence and Power
|
|
16
|
|
|
|
|
|
Section 4.2
|
|
Corporate Authorization
|
|
17
|
|
|
|
|
|
Section 4.3
|
|
Governmental Authorization
|
|
17
|
|
|
|
|
|
Section 4.4
|
|
Non-Contravention
|
|
18
|
|
|
|
|
|
Section 4.5
|
|
Capitalization
|
|
18
|
|
|
|
|
|
Section 4.6
|
|
Company Subsidiaries and Joint
Ventures
|
|
20
|
|
|
|
|
|
Section 4.7
|
|
Reports and Financial Statements
|
|
20
|
|
|
|
|
|
Section 4.8
|
|
Undisclosed Liabilities
|
|
21
|
|
|
|
|
|
Section 4.9
|
|
Disclosure Documents
|
|
21
|
|
|
|
|
|
Section 4.10
|
|
Absence of Certain Changes or Events
|
|
22
|
|
|
|
|
|
Section 4.11
|
|
Litigation
|
|
22
|
|
|
|
|
|
Section 4.12
|
|
Contracts
|
|
22
|
|
|
|
|
|
Section 4.13
|
|
Taxes
|
|
23
|
|
|
|
|
|
Section 4.14
|
|
ERISA
|
|
25
|
-i-
TABLE OF CONTENTS
(continued)
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
Section 4.15
|
|
Real Property
|
|
26
|
|
|
|
|
|
Section 4.16
|
|
Compliance With Laws
|
|
27
|
|
|
|
|
|
Section 4.17
|
|
Finders’ Fees
|
|
27
|
|
|
|
|
|
Section 4.18
|
|
Opinion of Financial Advisors
|
|
27
|
|
|
|
|
|
Section 4.19
|
|
Affiliate Transactions
|
|
27
|
|
|
|
|
|
Section 4.20
|
|
Rights Agreement; Anti-Takeover
Provisions
|
|
28
|
|
|
|
|
|
Section 4.21
|
|
Prior Merger Agreement
|
|
28
|
|
|
|
|
|
ARTICLE V
|
|
REPRESENTATIONS
AND WARRANTIES OF PARENT AND MERGER SUB
|
|
28
|
|
|
|
|
|
Section 5.1
|
|
Corporate Existence and Power
|
|
28
|
|
|
|
|
|
Section 5.2
|
|
Corporate Authorization
|
|
28
|
|
|
|
|
|
Section 5.3
|
|
Governmental Authorization
|
|
29
|
|
|
|
|
|
Section 5.4
|
|
Non-Contravention
|
|
29
|
|
|
|
|
|
Section 5.5
|
|
Disclosure Documents
|
|
29
|
|
|
|
|
|
Section 5.6
|
|
Finders’ Fees
|
|
29
|
|
|
|
|
|
Section 5.7
|
|
Financing
|
|
29
|
|
|
|
|
|
Section 5.8
|
|
[Intentionally Omitted]
|
|
30
|
|
|
|
|
|
Section 5.9
|
|
Operations of Merger Sub
|
|
30
|
|
|
|
|
|
Section 5.10
|
|
Litigation
|
|
31
|
|
|
|
|
|
Section 5.11
|
|
Solvency
|
|
31
|
|
|
|
|
|
Section 5.12
|
|
Debt Financing Commitment Conditions
|
|
31
|
|
|
|
|
|
ARTICLE VI
|
|
CONDUCT OF
BUSINESS PENDING THE MERGER
|
|
32
|
|
|
|
|
|
Section 6.1
|
|
Conduct of the Company and
Subsidiaries
|
|
32
|
|
|
|
|
|
Section 6.2
|
|
Conduct of Parent and Merger Sub
|
|
35
|
|
|
|
|
|
Section 6.3
|
|
No Control of Other Party’s
Business
|
|
35
|
|
|
|
|
|
ARTICLE VII
|
|
ADDITIONAL
AGREEMENTS
|
|
35
|
|
|
|
|
|
Section 7.1
|
|
Stockholder Meeting; Proxy Material
|
|
35
|
|
|
|
|
|
Section 7.2
|
|
Reasonable Best Efforts
|
|
37
|
|
|
|
|
|
Section 7.3
|
|
Access to Information
|
|
39
|
|
|
|
|
|
Section 7.4
|
|
Non-Solicitation
|
|
39
|
-ii-
TABLE OF CONTENTS
(continued)
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
Section 7.5
|
|
Director and Officer Liability
|
|
42
|
|
|
|
|
|
Section 7.6
|
|
Takeover Statutes
|
|
43
|
|
|
|
|
|
Section 7.7
|
|
Public Announcements
|
|
43
|
|
|
|
|
|
Section 7.8
|
|
Notice of Current Events
|
|
43
|
|
|
|
|
|
Section 7.9
|
|
Employee Matters
|
|
44
|
|
|
|
|
|
Section 7.10
|
|
Financing
|
|
45
|
|
|
|
|
|
Section 7.11
|
|
Actions with Respect to Existing Debt
|
|
48
|
|
|
|
|
|
Section 7.12
|
|
Stock Exchange Listing
|
|
50
|
|
|
|
|
|
Section 7.13
|
|
Insurance Matters
|
|
50
|
|
|
|
|
|
Section 7.14
|
|
Section 16(b)
|
|
50
|
|
|
|
|
|
Section 7.15
|
|
Resignation of Directors
|
|
50
|
|
|
|
|
|
Section 7.16
|
|
Shareholder Litigation
|
|
51
|
|
|
|
|
|
Section 7.17
|
|
Conveyance Taxes
|
|
51
|
|
|
|
|
|
Section 7.18
|
|
Prior Merger Agreement Termination and
Termination Fee
|
|
51
|
|
|
|
|
|
ARTICLE VIII
|
|
CONDITIONS TO THE MERGER
|
|
52
|
|
|
|
|
|
Section 8.1
|
|
Conditions to the Obligations of Each
Party
|
|
52
|
|
|
|
|
|
Section 8.2
|
|
Conditions to the Obligations of Parent and
Merger Sub
|
|
52
|
|
|
|
|
|
Section 8.3
|
|
Conditions of the Obligations of the
Company
|
|
53
|
|
|
|
|
|
ARTICLE IX
|
|
TERMINATION
|
|
54
|
|
|
|
|
|
Section 9.1
|
|
Termination
|
|
54
|
|
|
|
|
|
Section 9.2
|
|
Termination Fee
|
|
55
|
|
|
|
|
|
Section 9.3
|
|
Effect of Termination
|
|
57
|
|
|
|
|
|
ARTICLE X
|
|
MISCELLANEOUS
|
|
57
|
|
|
|
|
|
Section 10.1
|
|
Notices
|
|
57
|
|
|
|
|
|
Section 10.2
|
|
Representations and Warranties
|
|
58
|
|
|
|
|
|
Section 10.3
|
|
Expenses
|
|
58
|
|
|
|
|
|
Section 10.4
|
|
Amendment
|
|
58
|
|
|
|
|
|
Section 10.5
|
|
Waiver
|
|
59
|
|
|
|
|
|
Section 10.6
|
|
Successors and Assigns
|
|
59
|
|
|
|
|
|
Section 10.7
|
|
Governing Law
|
|
59
|
-iii-
TABLE OF CONTENTS
(continued)
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
Section 10.8
|
|
Counterparts; Effectiveness; Third Party
Beneficiaries
|
|
59
|
|
|
|
|
|
Section 10.9
|
|
Severability
|
|
59
|
|
|
|
|
|
Section 10.10
|
|
Entire Agreement
|
|
59
|
|
|
|
|
|
Section 10.11
|
|
Specific Performance
|
|
60
|
|
|
|
|
|
Section 10.12
|
|
Jurisdiction
|
|
60
|
|
|
|
|
|
Section 10.13
|
|
Authorship
|
|
61
|
-iv-
AGREEMENT AND PLAN OF
MERGER
This AGREEMENT AND PLAN OF MERGER
(this “ Agreement ”) is made and entered into as
of this 19th day of March, 2007, by and among Triad Hospitals,
Inc., a Delaware corporation (the “ Company ”),
Community Health Systems, Inc., a Delaware corporation (“
Parent ”), and FWCT-1 Acquisition Corporation, a
Delaware corporation and a wholly owned subsidiary of Parent
(“ Merger Sub ”).
RECITALS
WHEREAS, the parties intend that
Merger Sub be merged with and into the Company (the “
Merger ”), with the Company surviving the Merger as a
wholly owned subsidiary of Parent;
WHEREAS, immediately prior to
entering into this Agreement, the Company terminated the Agreement
and Plan of Merger, dated as of February 4, 2007, by and among
Panthera Partners, LLC, Panthera Holdco Corp., Panthera Acquisition
Corporation (collectively, “ Panthera ”) and the
Company (the “ Prior Merger Agreement
”);
WHEREAS, the respective boards of
directors of Parent, Merger Sub and the Company have determined
that it is in the best interests of their respective stockholders
for Parent to acquire the Company on the terms and subject to the
conditions set forth in this Agreement;
WHEREAS, the Board of Directors of
the Company, following the unanimous recommendation of the Special
Committee, has (i) determined that it is in the best interests
of the Company and its stockholders, and declared it advisable, to
terminate the Prior Merger Agreement and enter into this Agreement,
(ii) approved the execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated
hereby, including the Merger and (iii) resolved to recommend
adoption of this Agreement by the stockholders of the
Company;
WHEREAS, the members of the Boards
of Directors of Parent and Merger Sub have unanimously approved
this Agreement and declared it advisable for Parent and Merger Sub,
respectively, to enter into this Agreement; and
WHEREAS, the Company, Parent and
Merger Sub desire to make certain representations, warranties,
covenants and agreements in connection with the Merger and also to
prescribe certain conditions to the Merger, as set forth
herein.
AGREEMENT
NOW, THEREFORE, in consideration of
the foregoing and the representations, warranties, covenants and
agreements contained herein, intending to be legally bound, the
parties hereto agree as follows:
ARTICLE I
DEFINITIONS
Section 1.1 Definitions
. For purposes of this Agreement, the following terms have the
respective meanings set forth below:
“ Acceptable
Confidentiality Agreement ” has the meaning set forth in
Section 7.4(f)(i) .
“ Affiliate ”
means, with respect to any Person, any other Person, directly or
indirectly, controlling, controlled by, or under common control
with, such Person. For purposes of this definition, the term
“ control ” (including the correlative terms
“ controlling ”, “ controlled by
” and “ under common control with ”) means
the possession, directly or indirectly, of the power to direct or
cause the direction of the management and policies of a Person,
whether through the ownership of voting securities, by contract or
otherwise.
“ Agreement ” has
the meaning set forth in the Preamble.
“ Board of Directors
” means the board of directors of the Company.
“ Business Day ”
means any day other than the days on which banks in New York, New
York are required or authorized to close.
“ Certificate ”
has the meaning set forth in Section 3.1(d)
.
“ Certificate of Merger
” has the meaning set forth in Section 2.3
.
“ CIA ” has the
meaning set forth in Section 4.16(b) .
“ Closing ” has
the meaning set forth in Section 2.2 .
“ Closing Date ”
has the meaning set forth in Section 2.2 .
“ Code ” means
the Internal Revenue Code of 1986, as amended.
“ Common Stock ”
has the meaning set forth in Section 3.1(a)
.
“ Company ” has
the meaning set forth in the Preamble.
“ Company Acquisition
Proposal ” has the meaning set forth in
Section 7.4(f)(ii) .
“ Company Benefit Plans
” has the meaning set forth in Section 4.14(a)
.
“ Company Disclosure
Letter ” has the meaning set forth in the preamble to
Article IV .
“ Company Employees
” means any current, former or retired employee, officer,
consultant, independent contractor or director of the Company or
any of its Subsidiaries.
-2-
“ Company ERISA
Affiliate ” means any Person that, together with the
Company or any of its Subsidiaries is treated as a single employer
under Section 414(b), (c), (m) or (o) of the
Code.
“ Company ESOP ”
means that certain Employee Stock Ownership Plan, or the trust
established under such plan, established by the Company.
“ Company ESOP Debt
” means debt evidenced by that certain ESOP Loan and Pledge
Agreement dated June 10, 1999 by and between the Company and
U.S. Trust Company, N.A., as trustee of the Company
ESOP.
“ Company ESOP Shares
” means the Shares owned by the Company ESOP and unallocated
to participant accounts under the Company ESOP immediately prior to
the Effective Time.
“ Company Joint Venture
” means the Persons or other joint venture arrangements set
forth in Schedule 4.6(b) of the Company Disclosure
Letter.
“ Company Options
” means outstanding options to acquire Shares from the
Company granted under the Company Stock Plans.
“ Company Proxy
Statement ” has the meaning set forth in
Section 4.9 .
“ Company SEC Reports
” has the meaning set forth in Section 4.7(a)
.
“ Company Securities
” has the meaning set forth in Section 4.5(b)
.
“ Company Stockholder
Meeting ” has the meaning set forth in
Section 7.1(a) .
“ Company Stock Plans
” means the plans listed on Schedule 4.14(c) of the Company
Disclosure Letter whereby Company Options, RSUs or shares of Common
Stock have been or may be issued to employees, officers or
directors of the Company, its subsidiaries or its
predecessors.
“ Compensation ”
has the meaning set forth in Section 7.9(a)
.
“ Confidentiality
Agreement ” means the Confidentiality and Standstill
Agreement, dated as of February 9, 2007, by and between the
Company and Parent.
“ Consent Solicitation
” has the meaning set forth in Section 7.11(e)
.
“ Contract ” has
the meaning set forth in Section 4.4 .
“ Current Employee
” has the meaning set forth in Section 7.9(a)
.
“ Current Policy
” has the meaning set forth in Section 7.5(b)
.
“ Damages ” has
the meaning set forth in Section 7.5(a) .
-3-
“ Debt Financing
” has the meaning set forth in Section 5.7
.
“ Debt Financing
Commitments ” has the meaning set forth in
Section 5.7 .
“ Debt Offer ”
has the meaning set forth in Section 7.11(a)
.
“ Deemed Purchase
” has the meaning set forth in Section 3.3(d)
.
“ DGCL ” has the
meaning set forth in Section 2.1 .
“ Disclosed Conditions
” has the meaning set forth in Section 5.12
.
“ Dissenting Shares
” has the meaning set forth in Section 3.1(e)
.
“ DOJ ” has the
meaning set forth in Section 7.2(b) .
“ Effective Time
” has the meaning set forth in Section 2.3
.
“ Employee Benefit Plan
” has the meaning set forth in Section 3(3) of
ERISA.
“ End Date ” has
the meaning set forth in Section 9.1(b)(i) .
“ ERISA ” means
the Employee Retirement Income Security Act of 1974, as
amended.
“ Exchange Act ”
means the Securities Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder.
“ Existing Credit
Agreement ” means the credit agreement dated as of
June 10, 2005 by and among the Company, certain of its
Subsidiaries, Bank of America, N.A., as administrative agent, and
the lenders and other agents party thereto.
“ Existing Parent Notes
” has the meaning set forth in Section 7.10(c)
.
“ Facilities ”
means all hospitals, ambulatory centers, outpatient clinics,
long-term care facilities, nursing homes, rehabilitation
facilities, assisted living facilities, independent living
facilities or other healthcare facilities operated by the Company
or any of its Subsidiaries.
“ FTC ” has the
meaning set forth in Section 7.2(b) .
“ GAAP ” means
United States generally accepted accounting principles.
“ Governmental
Authority ” means any nation or government or any agency,
public or regulatory authority, instrumentality, department,
commission, court, arbitrator, ministry, tribunal or board of any
nation or government or political subdivision thereof, in each
case, whether national, federal, provincial, state, regional, local
or municipal.
“ HCA Tax Sharing
Agreement ” means the Tax Sharing and Indemnification
Agreement dated as of May 11, 1999 entered into by and among
Columbia/HCA Healthcare Corporation (now known as HCA Inc.),
LifePoint Hospitals, Inc., and the Company in connection with the
distribution by Columbia/HCA Healthcare Corporation to its
shareholders of all of the stock of LifePoint Hospitals, Inc. and
the Company.
-4-
“ HSR Act ” means
the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended.
“ Indentures ”
means: (i) the Senior Debt Securities Indenture, dated as of
May 6, 2004, between the Company and Citigroup, N.A., as
trustee, with respect to the 7% Senior Notes due 2012;
(ii) the First Supplemental Indenture, dated as of May 6,
2004, between the Company and Citibank, N.A. as trustee, with
respect to the 7% Senior Notes due 2012; and (iii) the
Indenture dated as of November 12, 2003, between the Company
and Citibank, N.A., as trustee, with respect to the 7% Senior
Subordinated Notes due 2013.
“ Initial Panthera
Termination Fee ” has the meaning set forth in
Section 7.18(a) .
“ Insurance Amount
” has the meaning set forth in Section 7.5(b)
.
“ Intercompany Debt
” means any loan, advance or other obligation solely among
the Company and/or any of its Subsidiaries.
“ IRS ” means the
Internal Revenue Service of the United States.
“ Knowledge ”
means the actual knowledge of the Persons set forth in Schedule 1.1
of the Company Disclosure Letter.
“ Law ” means
applicable statutes, common laws, rules, ordinances, regulations,
codes, orders, judgments, injunctions, writs, decrees, governmental
guidelines or interpretations having the force of law or bylaws, in
each case, of a Governmental Authority.
“ Leased Real Property
” means the real property that is used in the business of the
Company and its Subsidiaries as presently conducted that is leased
by the Company or any of its Subsidiaries, in each case as
tenant.
“ Liens ” means,
with respect to any asset, any mortgage, lien, pledge, charge,
security interest or encumbrance of any kind in respect of such
asset.
“ Marketing Period
” has the meaning set forth in Section 7.10(b)
.
“ Material Adverse Effect
on the Company ” means any event, state of facts,
circumstance, development, change, effect or occurrence that is
materially adverse to (x) the ability of the Company to timely
perform its obligations under this Agreement, or (y) the
business, financial condition or results of operations of the
Company and its Subsidiaries, taken as a whole, other than any
event, state of facts, circumstance, development, change, effect or
occurrence resulting from (A) changes in general economic or
political conditions or the securities, credit or financial markets
in general, (B) general changes or developments in the
industries in which the Company and its Subsidiaries operate,
including general changes in applicable Law across such industries,
(C) the announcement of this Agreement or the pendency of the
transactions contemplated hereby, including disputes or any fees or
expenses incurred in connection therewith or any labor
-5-
union activities or disputes, (D) the
identity of Parent or any of its Affiliates as the acquiror of the
Company, (E) compliance with the terms of, or the taking of
any action required by, this Agreement or consented to by Parent,
(F) any acts of terrorism or war or any natural disaster or
weather-related event (other than any of the foregoing that causes
any damage or destruction to or renders unusable any material
Facility of the Company or any of its Subsidiaries),
(G) changes in generally accepted accounting principles or the
interpretation thereof, (H) changes in the price or trading
volume of the Common Stock (provided that the underlying causes of
such price or volume changes nonetheless shall be considered in
determining whether there is a Material Adverse Effect on the
Company), (I) any legal proceedings made or brought by any of
the current or former stockholders of the Company (on their own
behalf or on behalf of the Company) arising out of or related to
this Agreement or the Merger, or (J) any failure to meet
internal or published projections, forecasts or revenue or earning
predictions for any period (provided that the underlying causes of
such failure nonetheless shall be considered in determining whether
there is a Material Adverse Effect on the Company except as
otherwise excluded from the definition of Material Adverse Effect
on the Company pursuant to this Agreement), except, in the case of
the foregoing clauses (A) and (B), to the extent such changes
or developments referred to therein would reasonably be expected to
have a materially disproportionate impact on the Company and its
Subsidiaries, taken as a whole, relative to other for profit
participants in the industries and in the geographic markets in
which the Company conducts its businesses after taking into account
the size of the Company relative to such other for profit
participants.
“ Material Contract
” has the meaning set forth in Section 4.12(a)
.
“ Merger ” has
the meaning set forth in the Recitals.
“ Merger Consideration
” has the meaning set forth in Section 3.1(d)
.
“ Merger Shares ”
has the meaning set forth in Section 3.1(d)
.
“ Merger Sub ”
has the meaning set forth in the Preamble.
“ Minority Joint
Venture ” means the Persons or other joint venture
arrangements set forth in Schedule 4.6(b) of the Company Disclosure
Letter.
“ Net SPP Payment
” has the meaning set forth in Section 3.3(d)
.
“ New Financing
Commitments ” has the meaning set forth in
Section 5.7 .
“ Notes ” has the
meaning set forth in Section 7.11(a) .
“ Notice Period ”
has the meaning set forth in Section 7.4(d)
.
“ Offer Documents
” has the meaning set forth in Section 7.11(b)
.
“ OIG ” has the
meaning set forth in Section 4.16(b) .
-6-
“ Owned Real Property
” means all real property owned in fee by the Company or any
of its Subsidiaries together with all appurtenant easements
thereunder or relating thereto and all structures, fixtures and
improvements located thereon.
“ Panthera ” has
the meaning set forth in the Recitals.
“ Panthera Parent
” has the meaning set forth in Section 7.18(a)
.
“ Panthera Termination
Fee ” has the meaning set forth in
Section 7.18(a) .
“ Parent ” has
the meaning set forth in the Preamble.
“ Parent Consent
Solicitation ” has the meaning set forth in
Section 7.10(c) .
“ Parent Disclosure
Letter ” has the meaning set forth in the preamble to
Article V.
“ Parent Expenses
” has the meaning set forth in Section 9.2(c)
.
“ Parent Tender Offer
” has the meaning set forth in
Section 7.10(c).
“ Participants ”
has the meaning set forth in Section 3.3(d)
.
“ Paying Agent ”
has the meaning set forth in Section 3.2(a)
.
“ PBGC ” has the
meaning set forth in Section 4.14(a) .
“ Permits ” means
any licenses, franchises, permits, certificates, consents,
approvals or other similar authorizations of, from or by a
Governmental Authority, possessed by, granted to or necessary for
the ownership of the material assets or conduct of the business of
the Company or its Subsidiaries.
“ Permitted Liens
” means (i) Liens for Taxes, assessments and
governmental charges or levies not yet due and payable or that are
being contested in good faith and by appropriate Proceedings;
(ii) mechanics, carriers’, workmen’s,
repairmen’s, materialmen’s or other Liens or security
interests that secure a liquidated amount that are being contested
in good faith and by appropriate Proceedings; (iii) leases,
subleases and licenses (other than capital leases and leases
underlying sale and leaseback transactions); (iv) Liens
imposed by applicable Law, (v) pledges or deposits to secure
obligations under workers’ compensation Laws or similar
legislation or to secure public or statutory obligations;
(vi) pledges and deposits to secure the performance of bids,
trade contracts, leases, surety and appeal bonds, performance bonds
and other obligations of a similar nature, in each case in the
ordinary course of business; (vii) easements, covenants and
rights of way (unrecorded and of record) and other similar
restrictions of record, and zoning, building and other similar
restrictions, in each case that do not adversely affect in any
material respect the current use of the applicable property owned,
leased, used or held for use by the Company or any of its
Subsidiaries; (viii) Liens relating to existing indebtedness,
the existence of which indebtedness is specifically disclosed in
any Company SEC Report filed prior to the date of this Agreement;
(ix) Liens permitted under or securing indebtedness pursuant
to the Existing Credit Agreement; and (x) any other Liens that
do not secure a liquidated amount, that
-7-
have been incurred or suffered in the ordinary
course of business and that would not, individually or in the
aggregate, have a material effect on the Company or the ability of
Parent to obtain the Debt Financing.
“ Person ” means
any individual, corporation, company, limited liability company,
partnership, association, trust, joint venture or any other entity
or organization, including any government or political subdivision
or any agency or instrumentality thereof.
“ Preferred Stock
” has the meaning set forth in Section 4.5(a)
.
“ Prior Merger
Agreement ” has the meaning set forth in the
Recitals.
“ Proceeding ”
has the meaning set forth in Section 4.11 .
“ Real Property ”
means the Owned Real Property together with the Leased Real
Property.
“ Real Property Leases
” has the meaning set forth in Section 4.15
.
“ Recommendation
” has the meaning set forth in Section 7.1(a)
.
“ Recommendation
Withdrawal ” has the meaning set forth in
Section 7.1(a) .
“ Representatives
” means the Company’s and its Subsidiaries’
officers, directors, employees, consultants, agents, advisors,
affiliates and other representatives.
“ Requested Consents
” has the meaning set forth in Section 7.11(e)
.
“ Required Financial
Information ” has the meaning set forth in
Section 7.10(a) .
“ Requisite Stockholder
Vote ” has the meaning set forth in
Section 4.2(a) .
“ Restricted Share
” has the meaning set forth in Section 3.3(b)
.
“ Rights Agreement
” has the meaning set forth in Section 4.20(a)
.
“ RSU ” has the
meaning set forth in Section 3.3(c) .
“ SEC ” means the
United States Securities and Exchange Commission.
“ Securities Act
” means the Securities Act of 1933, as amended, and the rules
and regulations promulgated thereunder.
“ Shares ” has
the meaning set forth in Section 3.1(a) .
“ Solvent ” has
the meaning set forth in Section 5.11 .
“ Special Committee
” means a committee of the Company’s Board of
Directors, the members of which are not affiliated with Parent or
Merger Sub and are not members of the Company’s management,
formed for the purpose of, among other things, evaluating, and
making a recommendation to the full Board of Directors of the
Company with respect to, this Agreement and the Merger.
-8-
“ Stock Purchase Plans
” has the meaning set forth in Section 3.3(d)
.
“ Subsidiary ”,
with respect to any Person, means any other Person of which the
first Person owns, directly or indirectly, securities or other
ownership interests having either (i) voting power to elect a
majority of the board of directors or other persons performing
similar functions, or (ii) beneficial ownership of more than
50% of the equity interests of the second Person. With respect to
the Company, the term “Subsidiary” shall not include
any Minority Joint Venture.
“ Superior Proposal
” has the meaning set forth in
Section 7.4(f)(iii) .
“ Surviving Corporation
” has the meaning set forth in Section 2.1
.
“ Surviving Corporation
Plan ” has the meaning set forth in
Section 7.9(b) .
“ Takeover Statute
” has the meaning set forth in Section 4.20(b)
.
“ Tax ” means
(i) all federal, state, local, foreign and other taxes
(including withholding taxes), customs, duties, imposts and other
similar governmental charges of any kind or nature whatsoever,
together with any interest and any penalties, additions or
additional amounts with respect thereto (whether disputed or not),
(ii) any liability for payment of amounts described in clause
(i) whether as a result of transferee liability, joint or
several liability for being a member of an affiliated,
consolidated, combined, unitary or other group for any period, or
otherwise by operation of law, and (iii) any liability for the
payment of amounts described in clause (i) or (ii) as a
result of any tax sharing, tax indemnity or tax allocation
agreement or any other express or implied agreement to pay or
indemnify any other Person.
“ Tax Return ”
means any return, declaration, report, statement, information
statement or other document filed or required to be filed with any
Governmental Authority with respect to Taxes, including any claims
for refunds of Taxes, any information returns and any amendments or
supplements of any of the foregoing.
“ Termination Fee
” means $130,000,000.
Section 1.2 Terms
Generally . The definitions in Section 1.1 shall
apply equally to both the singular and plural forms of the terms
defined. Whenever the context may require, any pronoun shall
include the corresponding masculine, feminine and neuter forms. The
words “ include ”, “ includes
” and “ including ” shall be deemed to be
followed by the phrase “ without limitation ”,
unless the context expressly provides otherwise. All references
herein to Sections, paragraphs, subparagraphs, clauses, Exhibits or
Schedules shall be deemed references to Sections, paragraphs,
subparagraphs or clauses of, or Exhibits or Schedules to this
Agreement, unless the context requires otherwise. Unless otherwise
expressly defined, terms defined in this Agreement have the same
meanings when used in any Exhibit or Schedule hereto, including the
Company Disclosure Letter. Unless otherwise specified, the words
“ this Agreement ”, “ herein
”, “ hereof ”, “ hereto
” and “ hereunder ” and other words of
similar import refer to this Agreement as a whole (including the
Schedules, Exhibits and the Company Disclosure Letter) and not to
any
-9-
particular provision of this Agreement. The term
“ or ” is not exclusive. The word “
extent ” in the phrase “ to the extent
” shall mean the degree to which a subject or other thing
extends, and such phrase shall not mean simply “ if
”. Any Contract, instrument or Law defined or referred to
herein means such Contract, instrument or Law as from time to time
amended, modified or supplemented, including (in the case of
Contracts or instruments) by waiver or consent and (in the case of
Laws) by succession of comparable successor Laws and references to
all attachments thereto and instruments incorporated therein.
References to a Person are also to such Person’s permitted
successors and assigns.
ARTICLE II
THE MERGER
Section 2.1 The Merger .
On the terms and subject to the conditions set forth in this
Agreement, and in accordance with the General Corporation Law of
the State of Delaware (the “ DGCL ”), at the
Effective Time, Merger Sub will merge with and into the Company
(the “ Merger ”), the separate corporate
existence of Merger Sub will cease and the Company will continue
its corporate existence under Delaware law as the surviving
corporation in the Merger (the “ Surviving Corporation
”).
Section 2.2 Closing .
Unless otherwise mutually agreed in writing by the Company and
Merger Sub, the closing of the Merger (the “ Closing
”) will take place at the offices of Kirkland &
Ellis LLP, 153 East 53rd Street, New York, New York, at 10:00 a.m.
on the third Business Day after the satisfaction or waiver of the
conditions set forth in Article VIII (excluding conditions
that, by their terms, cannot be satisfied until the Closing but
subject to the satisfaction or waiver of such conditions at the
Closing); provided , however , that if the Marketing
Period has not ended at the time of the satisfaction or waiver of
the conditions set forth in Article VIII (excluding
conditions that, by their terms, cannot be satisfied until the
Closing but subject to the satisfaction or waiver of such
conditions at the Closing), the Closing shall occur on the date
following the satisfaction or waiver of such conditions that is the
earliest to occur of (a) a date during the Marketing Period to
be specified by Merger Sub on no less than three Business
Days’ notice to the Company, (b) the final day of the
Marketing Period, and (c) the End Date. The date on which the
Closing actually occurs is hereinafter referred to as the “
Closing Date ”.
Section 2.3 Effective
Time . Subject to the provisions of this Agreement, at the
Closing, the Company will cause a certificate of merger (the
“ Certificate of Merger ”) to be executed,
acknowledged and filed with the Secretary of State of the State of
Delaware in accordance with Section 251 of the DGCL. The
Merger will become effective at such time as the Certificate of
Merger has been duly filed with the Secretary of State of the State
of Delaware or at such later date or time as may be agreed by the
Company and Merger Sub in writing and specified in the Certificate
of Merger in accordance with the DGCL (the effective time of the
Merger being hereinafter referred to as the “ Effective
Time ”).
Section 2.4 Effects of the
Merger . The Merger shall have the effects set forth in this
Agreement and the applicable provisions of the DGCL. Without
limiting the generality of the foregoing, and subject thereto, from
and after the Effective Time, all property, rights, privileges,
immunities, powers, franchises, licenses and authority of the
Company and Merger Sub shall
-10-
vest in the Surviving Corporation, and all
debts, liabilities, obligations, restrictions and duties of each of
the Company and Merger Sub shall become the debts, liabilities,
obligations, restrictions and duties of the Surviving
Corporation.
Section 2.5 Organizational
Documents . At the Effective Time, (a) the Certificate of
Incorporation of the Surviving Corporation shall be amended to read
in its entirety as the Certificate of Incorporation of Merger Sub
read immediately prior to the Effective Time, except that the name
of the Surviving Corporation shall be Triad Healthcare Corporation
and the provision in the Certificate of Incorporation of Merger Sub
naming its incorporator shall be omitted and (b) the bylaws of
the Surviving Corporation shall be amended so as to read in their
entirety as the bylaws of Merger Sub as in effect immediately prior
to the Effective Time, until thereafter amended in accordance with
applicable Law, except the references to Merger Sub’s name
shall be replaced by references to Triad Healthcare
Corporation.
Section 2.6 Directors and
Officers of Surviving Corporation . The directors and officers
of Merger Sub, in each case, as of the Effective Time shall, from
and after the Effective Time, be the directors and officers,
respectively, of the Surviving Corporation until their successors
have been duly elected or appointed and qualified or until their
earlier death, resignation or removal in accordance with the
certificate of incorporation or bylaws of the Surviving
Corporation.
ARTICLE III
EFFECT OF THE MERGER ON THE
CAPITAL STOCK
OF THE CONSTITUENT
CORPORATIONS
Section 3.1 Conversion of
Securities . At the Effective Time, pursuant to this Agreement
and by virtue of the Merger and without any action on the part of
the Company, Merger Sub or the holders of the Shares:
(a) Each share of Common Stock, par
value $.01 per share, of the Company (the “ Common
Stock ” or the “ Shares ”) held by the
Company (or any subsidiary of the Company) as treasury stock or
owned directly or indirectly by Parent or Merger Sub immediately
prior to the Effective Time (including any Shares acquired by
Parent, Merger Sub or any other subsidiary of Parent immediately
prior to the Effective Time) shall be canceled and retired and
shall cease to exist, and no payment or distribution shall be made
or delivered with respect thereto.
(b) [Intentionally
omitted]
(c) Each share of common stock, par
value $.01 per share, of Merger Sub issued and outstanding
immediately prior to the Effective Time shall be converted into and
become one newly issued, fully paid and non-assessable share of
common stock of the Surviving Corporation.
(d) Each Share (including any
Restricted Shares) issued and outstanding immediately prior to the
Effective Time (other than Shares to be canceled pursuant to
Section 3.1(a) and Dissenting Shares), automatically
shall be canceled and converted into the right to receive $54.00 in
cash, without interest (the “ Merger Consideration
”), payable to the holder
-11-
thereof upon surrender of the stock certificate
formerly representing such Share (a “ Certificate
”) in the manner provided in Section 3.2 . Such
Shares, other than those canceled pursuant to
Section 3.1(a) and Dissenting Shares, sometimes are
referred to herein as the “ Merger Shares
.”
(e) Notwithstanding any provision of
this Agreement to the contrary, if required by the DGCL (but only
to the extent required thereby), Shares that are issued and
outstanding immediately prior to the Effective Time (other than
Shares to be canceled pursuant to Section 3.1(a) ) and
that are held by holders of such Shares who have not voted in favor
of the adoption of this Agreement or consented thereto in writing
and who have properly exercised appraisal rights with respect
thereto in accordance with, and who have complied with,
Section 262 of the DGCL (the “ Dissenting Shares
”) will not be convertible into the right to receive the
Merger Consideration, and holders of such Dissenting Shares will be
entitled to receive payment of the fair value of such Dissenting
Shares in accordance with the provisions of such Section 262
unless and until any such holder fails to perfect or effectively
withdraws or loses its rights to appraisal and payment under the
DGCL. If, after the Effective Time, any such holder fails to
perfect or effectively withdraws or loses such right, such
Dissenting Shares will thereupon be treated as if they had been
converted into and have become exchangeable for, at the Effective
Time, the right to receive the Merger Consideration, without any
interest thereon, and the Surviving Corporation shall remain liable
for payment of the Merger Consideration for such Shares. At the
Effective Time, any holder of Dissenting Shares shall cease to have
any rights with respect thereto, except the rights provided in
Section 262 of the DGCL and as provided in the previous
sentence. The Company will give Parent (i) notice of any
demands received by the Company for appraisals of Shares and
(ii) the opportunity to participate in and direct all
negotiations and proceedings with respect to such notices and
demands. The Company shall not, except with the prior written
consent of Parent, make any payment with respect to any demands for
appraisal or settle any such demands.
(f) If between the date of this
Agreement and the Effective Time the number of outstanding Shares
is changed into a different number of shares or a different class,
by reason of any stock dividend, subdivision, reclassification,
recapitalization, split-up, combination, exchange of shares or the
like, other than pursuant to the Merger, the amount of Merger
Consideration payable per Merger Share shall be correspondingly
adjusted.
(g) For the avoidance of doubt, the
parties acknowledge and agree that the contribution of Shares
(including Restricted Shares) to Parent pursuant to any agreements
with holders of Shares (including Restricted Shares) shall be
deemed to occur immediately prior to the Effective Time and prior
to any other above-described event.
Section 3.2 Payment of Cash
for Merger Shares .
(a) Prior to the Closing Date, the
Company shall (i) designate a bank or trust company that is
reasonably satisfactory to Parent (the “ Paying Agent
”) and (ii) enter into a paying agent agreement, in form
and substance reasonably satisfactory to Parent, with such Paying
Agent, to serve as the Paying Agent for the Merger Consideration
and payments in respect of the Company Options, RSUs and Net SPP
Payments, unless another agent is designated as provided in
Section 3.3(a) , Section 3.3(c) and
Section 3.3(d) . Immediately following the Effective
Time, Parent and/or the Surviving Corporation will deposit, or
Parent
-12-
shall cause the Surviving Corporation to
deposit, with the Paying Agent cash in the aggregate amount
sufficient to pay the Merger Consideration in respect of all Merger
Shares outstanding immediately prior to the Effective Time plus any
cash necessary to pay for Company Options and RSUs outstanding
immediately prior to the Effective Time, as well as for Net SPP
Payments, pursuant to Section 3.3(a) ,
Section 3.3(c) and Section 3.3(d) . Pending
distribution of the cash deposited with the Paying Agent, such cash
shall be held in trust for the benefit of the holders of Merger
Shares, RSUs and Company Options outstanding immediately prior to
the Effective Time, as well as for Net SPP Payments, and shall not
be used for any other purposes; provided , however ,
that the Surviving Corporation may direct the Paying Agent to
invest such cash in (i) obligations of or guaranteed by the
United States of America or any agency or instrumentality thereof,
(ii) money market accounts, certificates of deposit, bank
repurchase agreement or banker’s acceptances of, or demand
deposits with, commercial banks having a combined capital and
surplus of at least $1,000,000,000 (based on the most recent
financial statements of such bank which are publicly available), or
(iii) commercial paper obligations rated P-1 or A-1 or better
by Standard & Poor’s Corporation or Moody’s
Investor Services, Inc. Any profit or loss resulting from, or
interest and other income produced by, such investments shall be
for the account of the Surviving Corporation.
(b) As promptly as practicable after
the Effective Time, the Surviving Corporation shall send, or cause
the Paying Agent to send, to each record holder of Merger Shares
entitled to receive the Merger Consideration a letter of
transmittal and instructions for exchanging their Merger Shares for
the Merger Consideration payable therefor. The letter of
transmittal will be in customary form and will specify that
delivery of Certificates (or effective affidavits of loss in lieu
thereof) will be effected, and risk of loss and title will pass,
only upon delivery of the Certificates (or effective affidavits of
loss in lieu thereof) to the Paying Agent. Upon surrender of
Certificate or Certificates (or effective affidavits of loss in
lieu thereof) to the Paying Agent together with a properly
completed and duly executed letter of transmittal and any other
documentation that the Paying Agent may reasonably require, the
record holder thereof shall be entitled to receive the Merger
Consideration payable in exchange therefor, less any amounts
required to be withheld for Tax. Until so surrendered and
exchanged, each such Certificate shall, after the Effective Time,
be deemed to represent only the right to receive the Merger
Consideration, and until such surrender and exchange, no cash shall
be paid to the holder of such outstanding Certificate in respect
thereof.
(c) If payment is to be made to a
Person other than the registered holder of the Merger Shares
formerly represented by the Certificate or Certificates surrendered
in exchange therefor, it shall be a condition to such payment that
the Certificate or Certificates so surrendered shall be properly
endorsed or otherwise be in proper form for transfer and that the
Person requesting such payment shall pay to the Paying Agent any
applicable stock transfer taxes required as a result of such
payment to a Person other than the registered holder of such Merger
Shares or establish to the reasonable satisfaction of the Paying
Agent that such stock transfer taxes have been paid or are not
payable.
(d) After the Effective Time, there
shall be no further transfers on the stock transfer books of the
Company of the Shares that were outstanding immediately prior to
the Effective Time other than to settle transfers of Shares that
occurred prior to the Effective Time. If, after the Effective Time,
Certificates are presented to the Surviving Corporation or the
Paying Agent, such shares shall be canceled and exchanged for the
consideration provided for, and in accordance with the procedures
set forth, in this Article III .
-13-
(e) If any cash deposited with the
Paying Agent remains unclaimed twelve months after the Effective
Time, such cash shall be returned to the Surviving Corporation upon
demand, and any holder who has not surrendered such holder’s
Certificates for the Merger Consideration prior to that time shall
thereafter look only to the Surviving Corporation for payment of
the Merger Consideration. Notwithstanding the foregoing, none of
Merger Sub, the Company, the Surviving Corporation or the Paying
Agent shall be liable to any holder of Certificates for any amount
paid to a public official pursuant to any applicable unclaimed
property laws. Any amounts remaining unclaimed by holders of
Certificates as of a date immediately prior to such time that such
amounts would otherwise escheat to or become property of any
Governmental Authority shall, to the extent permitted by applicable
Law, become the property of the Surviving Corporation on such date,
free and clear of any claims or interest of any Person previously
entitled thereto.
(f) No dividends or other
distributions with respect to capital stock of the Surviving
Corporation with a record date after the Effective Time shall be
paid to the holder of any unsurrendered Certificate, including
Dissenting Shares.
(g) From and after the Effective
Time, the holders of Shares (other than Dissenting Shares)
outstanding immediately prior to the Effective Time shall cease to
have any rights with respect to such Shares, other than the right
to receive the Merger Consideration as provided in this
Agreement.
(h) In the event that any
Certificate has been lost, stolen or destroyed, upon the making of
an affidavit of that fact by the Person claiming such Certificate
to be lost, stolen or destroyed, in addition to the posting by such
holder of any bond in such reasonable amount as the Surviving
Corporation or the Paying Agent may direct as indemnity against any
claim that may be made against the Surviving Corporation with
respect to such Certificate, the Paying Agent will issue in
exchange for such lost, stolen or destroyed Certificate the proper
amount of the Merger Consideration in respect thereof entitled to
be received pursuant to this Agreement.
(i) Parent, the Surviving
Corporation and the Paying Agent shall be entitled to deduct and
withhold from the Merger Consideration otherwise payable hereunder
and any amounts to be paid hereunder in respect of Company Options,
RSUs or Net SPP Payments any amounts required to be deducted and
withheld under any applicable Tax Law. To the extent any amounts
are so withheld, such withheld amounts shall be timely paid to the
applicable Tax authority and shall be treated for all purposes as
having been paid to the holder from whose Merger Consideration (or
amounts payable hereunder with respect to Company Options, RSUs or
Net SPP Payments) the amounts were so deducted and
withheld.
Section 3.3 Treatment of
Options and Other Awards .
(a) As of the Effective Time, except
as otherwise agreed by Parent and the holder of Company Options
with respect to such holder’s Company Options, each Company
Option will be cancelled and extinguished, and the holder thereof
will be entitled to receive an
-14-
amount in cash equal to the excess (if any) of
(A) the product of (i) the number of Shares subject to
such Company Option and (ii) the Merger Consideration over
(B) the aggregate exercise price of such Company Option,
without interest and less any amounts required to be deducted and
withheld under any applicable Law. All payments with respect to
canceled Company Options shall be made by the Paying Agent (or such
other agent reasonably acceptable to Parent as the Company shall
designate prior to the Effective Time) as promptly as reasonably
practicable after the Effective Time from funds deposited by or at
the direction of the Surviving Corporation to pay such amounts in
accordance with Section 3.2(a) .
(b) As of the Effective Time, except
as otherwise agreed by Parent and the holder of a Share subject to
vesting or other lapse restrictions pursuant to any Company Stock
Plan or any applicable restricted stock award agreement (each a
“ Restricted Share ”) with respect to such
holder’s Restricted Shares, each Restricted Share outstanding
immediately prior to the Effective Time shall vest and become free
of such restrictions as of the Effective Time and shall, as of the
Effective Time, be canceled and converted into the right to receive
the Merger Consideration in accordance with
Section 3.1(d) .
(c) As of the Effective Time, except
as otherwise agreed by Parent and the holder of awards of a right
under any Company Stock Plan entitling the holder thereof to
Restricted Shares, shares of Common Stock or cash equal to or based
on the value of Common Stock (collectively, “ RSUs
”) with respect to such holder’s RSUs, each RSU
outstanding immediately prior to the Effective Time, shall vest, if
applicable, and become free of any lapse restriction (without
regard to whether the RSUs are then vested or the applicable
restrictions have lapsed) and, as of the Effective Time be
canceled, and at the Effective Time, the holder thereof shall be
entitled to receive an amount in cash equal to the (i) product
of (A) the number of Shares previously subject to such RSU and
(B) the Merger Consideration, and (ii) the value of any
deemed dividend equivalents accrued but unpaid with respect to such
RSUs, less any amounts required to be withheld under any applicable
Law. All payments with respect to canceled RSUs shall be made by
the Paying Agent (or such other agent reasonably acceptable to
Parent as the Company shall designate prior to the Effective Time)
as promptly as reasonably practicable after the Effective Time from
funds deposited by or at the direction of the Surviving Corporation
to pay such amounts in accordance with Section 3.2(a)
.
(d) At the Effective Time, all
amounts withheld by the Company on behalf of the participants in
the Company’s Amended and Restated Management Stock Purchase
Plan and the Company’s Employee Stock Purchase Plan (the
“ Stock Purchase Plans ”, and such participants,
the “ Participants ”) from the beginning of the
applicable existing salary reduction periods through the Effective
Time will be deemed to have been used to purchase Common Stock
pursuant to the terms of the Stock Purchase Plans, using the
Effective Time as the last date of the applicable salary reduction
period under the Stock Purchase Plans (the “ Deemed
Purchase ”) and each such share of Common Stock will be
deemed to have been cancelled and converted into the right to
receive the Merger Consideration, such that, as of the Effective
Time, on a net basis, each Participant shall be entitled to
receive, without interest and less any amounts required to be
deducted and withheld under any applicable Law, (i) a refund
by the Company of all reductions made pursuant to the Stock
Purchase Plans by the Participant during the applicable existing
salary reduction periods and (ii) an amount in cash equal to
the excess (if any) of (A) the product of (1) the number
of Shares that the Participant is deemed to have acquired pursuant
to
-15-
the terms of the applicable Stock Purchase Plan
pursuant to the applicable Deemed Purchase and (2) the Merger
Consideration, over (B) the aggregate amount of the
Participant’s purchase price deemed to have been paid in the
Deemed Purchase (such cash amount described in (ii) being the
“ Net SPP Payment ”). All Net SPP Payments shall
be paid by the Paying Agent (or such other agent reasonably
acceptable to Parent as the Company shall designate prior to the
Effective Time) as promptly as reasonably practicable after the
Effective Time from funds deposited by or at the direction of the
Surviving Corporation to pay such amounts in accordance with
Section 3.2(a) . However, in connection with the
foregoing, if and to the extent permitted by the applicable Stock
Purchase Plan, on or after the date of this Agreement, in no event
(i) shall any person who is not currently participating in any
Stock Purchase Plan be permitted to begin participating in any
Stock Purchase Plan, and (ii) shall any person who is
currently participating in any Stock Purchase Plan be permitted to
increase the level of salary reduction amount that may otherwise be
deemed used to purchase shares of Common Stock under any Stock
Purchase Plan from that level of salary reduction amount in effect
as of the date of this Agreement; and provided ,
further , that in no event may any new salary reduction
period commence after the date hereof and prior to the Effective
Time.
(e) Prior to the Effective Time, the
Company will (i) (A) use its reasonable best efforts to
obtain any consents from the holders of Company Options, and
(B) to the extent the Company does not obtain all of such
consents, make any amendments to the terms of any Company Stock
Plan that in the case of either clause (A) or (B), are
necessary to give effect to the transactions contemplated by
Section 3.3(a) and (ii) adopt such resolutions and
will take such other actions as may be reasonably required to
effectuate the actions contemplated by this Section 3.3
, without paying any consideration or incurring any debts or
obligations on behalf of the Company or the Surviving
Corporation.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF
THE COMPANY
Except as set forth in the
corresponding sections or subsections of the disclosure letter
delivered to Parent and Merger Sub by the Company concurrently with
entering into this Agreement (the “ Company Disclosure
Letter ”) (it being agreed that disclosure of any item in
any section or subsection of the Company Disclosure Letter shall be
deemed to be disclosed with respect to any other section or
subsection to which the relevance of such disclosure is reasonably
apparent) or as may be disclosed in the Company SEC Reports filed
prior to the date of this Agreement (other than disclosure that
constitutes a “risk factor” or a “forward looking
statement” under the heading “Forward Looking
Statements” in any such Company SEC Reports, provided,
however, that any such “risk factor” or “forward
looking statement” disclosure shall not supersede or
otherwise limit the effectiveness of similar disclosure made in the
exceptions set forth in clauses (A) through (J) in the
definition of Material Adverse Effect on the Company or in the
Company Disclosure Letter), the Company hereby represents and
warrants to Parent and Merger Sub as follows:
Section 4.1 Corporate
Existence and Power . The Company and each of its Subsidiaries
is duly organized, validly existing and in good standing under the
laws of its jurisdiction (with respect to jurisdictions that
recognize the concept of good standing), except in
-16-
the case of the Company’s Subsidiaries,
where the failure to be so organized, existing and in good standing
has not had, and would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company. The Company and each of its Subsidiaries has all corporate
or similar powers and authority required to own, lease and operate
its respective properties and to carry on its business as now
conducted, except in the case of the Company’s Subsidiaries,
where the failure to have such power and authority has not had, and
would not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company. The Company
and each of its Subsidiaries is duly licensed or qualified to do
business in each jurisdiction in which the nature of the business
conducted by it or the character or location of the properties and
assets owned or leased by it makes such qualification necessary,
except where the failure to be so licensed or qualified has not
had, and would not reasonably be expected to have, individually or
in the aggregate, a Material Adverse Effect on the Company. None of
the Company or its Subsidiaries is in violation of its
organizational or governing documents in any material
respect.
Section 4.2 Corporate
Authorization .
(a) The Company has the corporate
power and authority to execute and deliver this Agreement and,
subject to the adoption of this Agreement by the affirmative vote
of the holders of a majority of the outstanding shares of Common
Stock (the “ Requisite Stockholder Vote ”), to
consummate the Merger and the other transactions contemplated
hereby and to perform each of its obligations hereunder. The
termination of the Prior Merger Agreement, the execution, delivery
and performance by the Company of this Agreement and the
consummation by the Company of the Merger and the other
transactions contemplated hereby have been duly and validly
authorized by the Board of Directors of the Company. Except for the
adoption of this Agreement by the Requisite Stockholder Vote, no
other corporate proceedings on the part of the Company are
necessary to approve this Agreement or to consummate the Merger or
the other transactions contemplated hereby. The Board of Directors
of the Company, following the unanimous recommendation of the
Special Committee, at a duly held meeting has (i) determined
that it is in the best interests of the Company and its
stockholders (other than holders of Shares that are Affiliates of
Parent), and declared it advisable, to terminate the Prior Merger
Agreement and enter into this Agreement, (ii) approved the
termination of the Prior Merger Agreement, the execution, delivery
and performance of this Agreement and the consummation of the
transactions contemplated hereby, including the Merger, and
(iii) resolved to recommend that the stockholders of the
Company approve the adoption of this Agreement and directed that
such matter be submitted for consideration of the stockholders of
the Company at the Company Stockholder Meeting.
(b) This Agreement has been duly and
validly executed and delivered by the Company and, assuming the due
and valid execution and delivery of this Agreement by Parent and
Merger Sub, constitutes a legal, valid and binding agreement of the
Company enforceable against the Company in accordance with its
terms, except as such enforceability may be limited by bankruptcy,
insolvency, moratorium, reorganization or similar Laws affecting
the enforcement of creditors’ rights generally and general
equitable principles.
Section 4.3 Governmental
Authorization . The execution, delivery and performance by the
Company of this Agreement and the consummation by the Company of
the Merger do not
-17-
and will not require any consent, approval,
authorization or permit of, action by, filing with or notification
to any Governmental Authority, other than (i) the filing of
the Certificate of Merger; (ii) compliance with the applicable
requirements of the HSR Act; (iii) the applicable requirements
of the Exchange Act including the filing of the Company Proxy
Statement; (iv) compliance with the rules and regulations of
the New York Stock Exchange; (v) compliance with any
applicable state securities or blue sky laws; (vi) the
consents and/or notices listed in Schedule 4.3 of the Company
Disclosure Letter; and (vii) any such consent, approval,
authorization, permit, action, filing or notification the failure
of which to make or obtain would not (A) individually or in
the aggregate, reasonably be expected to have a Material Adverse
Effect on the Company or (B) reasonably be expected to prevent
or materially delay the consummation of the Merger.
Section 4.4
Non-Contravention . The termination of the Prior Merger
Agreement, the execution, delivery and performance by the Company
of this Agreement and the consummation by the Company of the Merger
and the other transactions contemplated hereby do not and will not
(i) contravene or conflict with, or result in any violation or
breach of any provision of, the organizational or governing
documents of (A) the Company or (B) any of its
Subsidiaries; (ii) assuming compliance with the matters
referenced in Section 4.3 and the receipt of the
Requisite Stockholder Vote, contravene or conflict with or
constitute a violation of any provision of any Law binding upon or
applicable to the Company or any of its Subsidiaries or any of
their respective properties or assets; (iii) require the
consent, approval or authorization of, or notice to or filing with
any third party with respect to, or result in any breach or
violation of, or constitute a default (or an event which with
notice or lapse of time or both would become a default) or result
in the loss of benefit under, or give rise to any right of
termination, cancellation, amendment or acceleration of, any right
or obligation of the Company or any of its Subsidiaries, or result
in the creation of any Lien (other than Permitted Liens) on any of
the properties or assets of the Company or any of its Subsidiaries
under any loan or credit agreement, note, bond, mortgage,
indenture, contract, agreement, Real Property Lease, license,
permit or other instrument or obligation (each, a “
Contract ”) to which the Company or any of its
Subsidiaries is a party or by which the Company or any of its
Subsidiaries or its or any of their respective properties or assets
are bound, except in the case of clauses (i)(B), (ii) and
(iii) above, which would not (A) individually or in the
aggregate, reasonably be expected to have a Material Adverse Effect
on the Company or (B) reasonably be expected to prevent or
materially delay the consummation of the Merger.
Section 4.5
Capitalization .
(a) The authorized share capital of
the Company consists of 120,000,000 shares of Common Stock and
10,000,000 shares of Preferred Stock, par value $0.01 per share
(the “ Preferred Stock ”), of which 90,000
shares are designated Series A Junior Participating Preferred
Stock. As of February 28, 2007, there were
(i) (A) 89,111,035 shares of Common Stock issued and
outstanding (including 1,415,031 Restricted Shares), and
(B) no shares of Preferred Stock issued and outstanding,
(ii) Company Options to purchase an aggregate of 6,771,437
shares of Common Stock, with a weighted average exercise price of
$33.79 per share, issued and outstanding and (iii) 1,083,737
shares of Common Stock available for issuance under the Stock
Purchase Plans. The Company shall deliver a supplement to Schedule
4.5(a) of the Company Disclosure Letter to Parent no later than the
close of business on March 20, 2007,
-18-
which supplement shall provide the numbers in
clauses (i) - (iii) in the immediately preceding sentence as of the
close of business on March 19, 2007. Between February 28,
2006 and the date of this Agreement, the Company has not issued any
Shares, shares of Preferred Stock or Company Options other than
issuances that would not have been prohibited under
Section 6.1(m) if such issuances had occurred between the date
of this Agreement and the Effective Time. All outstanding Shares
are duly authorized, validly issued, fully paid and non-assessable,
and are not subject to and were not issued in violation of any
preemptive or similar right, purchase option, call or right of
first refusal or similar right. No Subsidiaries of the Company own
any Shares or any other equity securities of the
Company.
(b) Except as set forth in Schedule
4.5(b) of the Company Disclosure Letter and except with respect to
the Stock Purchase Plans, there have not been reserved for
issuance, and there are no outstanding: (i) shares of capital
stock or other voting securities of the Company;
(ii) securities of the Company or any of its Subsidiaries
convertible into or exchangeable for shares of capital stock or
voting securities of the Company or any of its Subsidiaries, other
than Company Options; (iii) Company Options or other rights or
options to acquire from the Company or any of its Subsidiaries, or
obligations of the Company or any of its Subsidiaries to issue, any
shares of capital stock, voting securities or securities
convertible into or exchangeable for shares of capital stock or
voting securities of the Company or such Subsidiary, as the case
may be; or (iv) equity equivalent interests in the ownership
or earnings of the Company or any of its Subsidiaries or other
similar rights (the items in clauses (i) through
(iv) collectively, “ Company Securities ”).
There are no outstanding obligations of the Company or any of its
Subsidiaries to repurchase, redeem or otherwise acquire any Company
Securities. There are no preemptive rights of any kind which
obligate the Company or any of its Subsidiaries to issue or deliver
any Company Securities. There are no stockholder agreements, voting
trusts or other agreements or understandings to which the Company
or any of its Subsidiaries is a party or by which it is bound
relating to the voting or registration of any shares of capital
stock of the Company or any of its Subsidiaries or preemptive
rights with respect thereto.
(c) Except as set forth in Schedule
4.5(c) of the Company Disclosure Letter, since September 30,
2006, the Company has not declared or paid any dividend or
distribution in respect of any Company Securities issued by the
Company other than the issuance of shares upon the exercise of
Company Options, and neither the Company nor any of its
Subsidiaries has issued, sold, repurchased, redeemed or otherwise
acquired any Company Securities issued by the Company, and their
respective Boards of Directors have not authorized any of the
foregoing.
(d) Except as set forth in Schedule
4.5(d) of the Company Disclosure Letter, neither the Company nor
any of its Subsidiaries has entered into any commitment,
arrangement or agreement, or are otherwise obligated, to contribute
capital, loan money or otherwise provide funds or make additional
investments in any Company Joint Venture, Minority Joint Venture or
any other Person, other than Intercompany Debt and other than any
such commitment, arrangement or agreement entered into in the
ordinary course of business consistent with past
practice.
(e) No bonds, debentures, notes or
other indebtedness having the right to vote generally on any
matters on which stockholders of the Company may vote are
outstanding.
-19-
Section 4.6 Company
Subsidiaries and Joint Ventures .
(a) Schedule 4.6(a) of the Company
Disclosure Letter sets forth a list of all the Company’s
Subsidiaries.
(b) Schedule 4.6(b) of the Company
Disclosure Letter sets forth a list of all Company Joint Ventures
and all Minority Joint Ventures.
(c) All equity interests of any
Subsidiary and any Minority Joint Venture held by the Company or
any other Subsidiary are validly issued, fully paid and
non-assessable and were not issued in violation of any preemptive
or similar rights, purchase option, call, or right of first refusal
or similar rights. All such equity interests are free and clear of
any Liens or any other limitations or restrictions on such equity
interests (including any limitation or restriction on the right to
vote, pledge or sell or otherwise dispose of such equity interests)
other than Permitted Liens. The Company has made available to
Parent or its employees, consultants, agents, advisors, affiliates
or other representatives true, correct and complete copies of the
organizational or governing documents of the Company’s
Subsidiaries, and to the Knowledge of the Company, the Minority
Joint Ventures.
Section 4.7 Reports and
Financial Statements .
(a) The Company has filed all forms,
reports, statements, certifications and other documents (including
all exhibits, amendments and supplements thereto) required to be
filed by it with the SEC pursuant to the Exchange Act or other
applicable United States federal securities Laws since
January 1, 2004 (all such forms, reports, statements,
certificates and other documents filed since January 1, 2004,
with any amendments thereto, collectively, the “ Company
SEC Reports ”), each of which, including any financial
statements or schedules included therein, as finally amended prior
to the date of this Agreement, has complied as to form in all
material respects with the applicable requirements of the
Securities Act and Exchange Act as of the date filed with the SEC.
None of the Company’s Subsidiaries is required to file
periodic reports with the SEC. None of the Company SEC Reports when
filed with the SEC and, if amended, as of the date of such
amendment contained any untrue statement of a material fact or
omitted to state a material fact required to be stated or
incorporated by reference therein or necessary in order to make the
statements therein, in the light of the circumstances under which
they were made, not misleading.
(b) Each of the consolidated
financial statements of the Company and its Subsidiaries included
(or incorporated by reference) in the Company SEC Reports
(including the related notes and schedules, where applicable)
fairly presents (subject, in the case of the unaudited statements,
to the absence of notes and normal year-end audit adjustments as
permitted by the rules related to Quarterly Reports on Form 10-Q
promulgated under the Exchange Act), in all material respects, the
results of the consolidated operations and changes in
stockholders’ equity and cash flows and consolidated
financial position of the Company and its Subsidiaries for the
respective fiscal periods or as of the respective dates therein set
forth. Each of such consolidated financial statements (including
the related notes and schedules, where applicable) complies in all
material respects with applicable accounting requirements and with
the published rules and regulations of the SEC with respect thereto
and each of such financial statements
-20-
(including the related notes and schedules,
where applicable) were prepared in accordance with GAAP
consistently applied during the periods involved, except in each
case as indicated in such statements or in the notes thereto or, in
the case of unaudited statements, as permitted by the rules related
to Quarterly Reports on Form 10-Q promulgated under the Exchange
Act.
(c) Except as has not had, and would
not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company, the management
of the Company (i) has implemented and maintains disclosure
controls and procedures (as defined in Rule 13a-15(e) of the
Exchange Act) to ensure that material information relating to the
Company, including its consolidated Subsidiaries, is made known to
the chief executive officer and the chief financial officer of the
Company by others within those entities and (ii) has
disclosed, based on its most recent evaluation prior to the date of
this Agreement, to the Company’s outside auditors and the
audit committee of the Board of Directors of the Company
(x) any significant deficiencies and material weaknesses in
the design or operation of internal controls over financial
reporting (as defined in Rule 13a-15(f) of the Exchange Act) which
are reasonably likely to adversely affect the Company’s
ability to record, process, summarize and report financial
information and (y) any fraud, known to the Company, whether
or not material, that involves management or other employees who
have a significant role in the Company’s internal controls
over financial reporting.
Section 4.8 Undisclosed
Liabilities . Except (i) for those liabilities that are
reflected or reserved against on the consolidated balance sheet of
the Company (including the notes thereto) included in the
Company’s Annual Report on Form 10-K for the year ended
December 31, 2006, (ii) for liabilities incurred in the
ordinary course of business consistent with past practice since
December 31, 2006, (iii) for liabilities that have been
discharged or paid in full prior to the date of this Agreement in
the ordinary course of business, (iv) for liabilities incurred
in connection with the transactions contemplated hereby, including
the termination of the Prior Merger Agreement, or (v) for
liabilities that would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company, neither the Company nor any of its Subsidiaries has
incurred any liability of any nature whatsoever (whether absolute,
accrued or contingent or otherwise and whether due or to become
due).
Section 4.9 Disclosure
Documents . The proxy statement relating to the Merger (the
“ Company Proxy Statement ”) to be filed by the
Company with the SEC in connection with seeking the adoption of
this Agreement by the stockholders of the Company will not, at the
time it is first mailed to the stockholders of the Company, or at
the time of the Company Stockholder Meeting, contain any untrue
statement of a material fact or omit to state any material fact
required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they
are made, not misleading. The Company will cause the Company Proxy
Statement to comply as to form in all material respects with the
requirements of the Exchange Act applicable thereto as of the date
of such filing. No representation is made by the Company with
respect to statements made in the Company Proxy Statement and any
other documents required to be filed by the Company with the SEC
relating to the Merger and the transactions contemplated hereby
based on information supplied, or required to be supplied, by
Parent, Merger Sub or any of their Affiliates specifically for
inclusion or incorporation by reference therein.
-21-
Section 4.10 Absence of
Certain Changes or Events . Since December 31, 2005 to the
date of this Agreement, except as otherwise contemplated or
permitted by this Agreement, (i) there has not been any event,
state of facts, circumstance, development, change, effect or
occurrence that, individually or in the aggregate, has had or would
reasonably be expected to have a Material Adverse Effect on the
Company, and (ii) the businesses of the Company and its
Subsidiaries have been carried on in all material respects in the
ordinary course of business.
Section 4.11 Litigation
. Except as set forth on Schedule 4.11 of the Company Disclosure
Letter, none of the Company, its Subsidiaries or, to the Knowledge
of the Company, the Minority Joint Ventures is a party to any, and
there are no pending or, to the Knowledge of the Company,
threatened, legal, administrative, arbitral or other material
proceedings, claims, actions or governmental or regulatory
investigations (a “ Proceeding ”) of any nature
against the Company, any of its Subsidiaries or, to the Knowledge
of the Company, any Minority Joint Venture, except for any
Proceeding which (i) is not reasonably expected as of the date
of this Agreement to involve an amount in controversy in excess of
$10,000,000, or (ii) has not had, or would not reasonably be
expected to have, individually or in the aggregate, a Material
Adverse Effect on the Company. Except as set forth on Schedule 4.11
of the Company Disclosure Letter, none of the Company, its
Subsidiaries, or, to the Knowledge of the Company, the Minority
Joint Ventures, or any of their businesses or properties are
subject to or bound by any injunction, order, judgment, decree,
settlement agreement, ruling or regulatory restriction of any
Governmental Authority specifically imposed upon the Company, any
of its Subsidiaries, any Minority Joint Venture or their respective
properties or assets, except for any injunction, order, judgment,
decree, settlement agreement, ruling or regulatory restriction
which has not had, or would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company.
Section 4.12 Contracts
.
(a) The Company has made available
to Parent or its employees, consultants, agents, advisors,
affiliates or other representatives, as of the date of this
Agreement, true, correct and complete copies of (including all
amendments or modification to), all Contracts (including with
respect to personal property) to which the Company or any of its
Subsidiaries is a party or by which the Company, any of its
Subsidiaries, or any of their respective properties or assets is
bound that:
(i) contain covenants that prohibit
the Company or any of its Subsidiaries (or which, immediately
following the consummation of the Merger, would prohibit the
Surviving Corporation) from competing in any business or with any
Person or in any geographic area, or acquiring any Person, except
any such contract that may be cancelled without any penalty or
other liability to the Company or any of its Subsidiaries upon
notice of 60 days or less;
(ii) were entered into after
December 31, 2005 or not yet consummated, and involve the
acquisition from another Person or disposition to another Person,
directly or indirectly (by merger or otherwise), of assets or
capital stock or other equity interests of another Person for
aggregate consideration under such contract in excess of
$25,000,000 (other than acquisitions or dispositions of assets in
the ordinary course of business, including acquisitions and
dispositions of inventory);
-22-
(iii) other than an acquisition
permitted under clause (ii) above, provide for aggregate
commitments by the Company and/or its Subsidiaries of more than
$25,000,000 over the remaining term of such Contract (other than
Contracts providing for procurement of supplies in the ordinary
course of business); and
(iv) contain restrictions with
respect to payment of dividends or any distributions in respect of
the capital stock or other equity interests of the Company or any
of its Subsidiaries.
Each Contract of the type described
in clauses (i) through (iv) is referred to herein as a
“ Material Contract .”
(b) Except as has not had and would
not reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect on the Company, (i) each
Material Contract is valid and binding on the Company, or any
Subsidiary that is a party thereto and, to the Knowledge of the
Company, each other party thereto and is in full force and effect,
and (ii) the Company and its Subsidiaries have performed and
complied with all obligations required to be performed or complied
with by them under each Material Contract. There is no default
under any Material Contract by the Company, or any of its
Subsidiaries, or, to the Knowledge of the Company, by any other
party thereto, and no event has occurred that with the lapse of
time or the giving of notice or both would constitute a default
thereunder by the Company, any of its Subsidiaries, or to the
Knowledge of the Company, any other party thereto, except which has
not had and would not reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on the
Company.
Section 4.13 Taxes
.
The representations and warranties
contained in Section 4.7(b) , this
Section 4.13 and Section 4.14 are the only
representations and warranties being made by the Company with
respect to Taxes related to the Company, any of its Subsidiaries,
or any Minority Joint Venture or this Agreement or its subject
matter, and no other representation or warranty contained in any
other section of this Agreement shall apply to any such Tax matters
and no other representation or warranty, express or implied, is
being made with respect thereto.
(a) All Tax Returns required to be
filed with any Governmental Authority by or with respect to the
Company or any of its Subsidiaries have been properly prepared and
timely filed, and all such Tax Returns (including information
provided therewith or with respect thereto) are true, correct and
complete, except for Tax Returns as to which the failure to so file
or be true, correct and complete would not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect
on the Company.
(b) The Company and its Subsidiaries
(i) have fully and timely paid all Taxes (whether or not shown
to be due on the Tax Returns referred to in
Section 4.13(a) , except for Taxes being contested in
good faith and for which adequate reserves have been established in
accordance with GAAP and for Taxes as to which the failure to pay
would not reasonably be
-23-
expected, individually or in the aggregate, to
have a Material Adverse Effect on the Company, and (ii) have
made adequate provision in the applicable financial statements in
accordance with GAAP for any material Tax that is not yet due and
payable for all taxable periods, or portions thereof, ending on or
before the date of this Agreement, and there are no Liens for Taxes
upon their assets other than (i) Permitted Liens and
(ii) Liens which would not reasonably be expected,
individually or in the aggregate, to have a Material Adverse Effect
on the Company.
(c) No audit or other Proceeding by
any Governmental Authority is pending or threatened in writing with
respect to any Taxes due from or with respect to the Company or any
of its Subsidiaries, except for such audits, investigations and
Proceedings that would not reasonably be expected, individually or
in the aggregate, to have a Material Adverse Effect on the Company.
No deficiencies for any Taxes have been proposed, asserted or
assessed against the Company or any of its Subsidiaries that have
not been paid, except for deficiencies (i) as to which
adequate reserves have been established, (ii) which have been
set forth in Schedule 4.13(c) of the Company Disclosure Letter or
(iii) as to which the failure to pay would not reasonably be
expected, individually or in the aggregate, to have a Material
Adverse Effect on the Company. None of the Company or any of its
Subsidiaries has entered into a “closing agreement” as
described in Section 7121 of the Code (or any corresponding or
similar provision of state or local income Tax Law) executed prior
to the Closing date that would require the Company or any of its
Subsidiaries to include any item of income in, or exclude any item
of deduction from, taxable income for any taxable period after the
Closing Date, which would reasonably be expected, individually or
in the aggregate, to have a Material Adverse Effect on the
Company.
(d) There are no Tax sharing
agreements (or similar agreements) under which the Company or any
of its Subsidiaries could be liable for the Tax liability of an
entity that is neither the Company nor any of its Subsidiaries,
except for (i) the HCA Tax Sharing Agreement, and
(ii) such agreements that would not reasonably be expected,
individually or in the aggregate, have a Material Adverse Effect on
the Company.
(e) Neither the Company nor any of
its Subsidiaries have entered into a “listed
transaction” that has given rise to a disclosure obligation
under Section 6011 of the Code and the Treasury Regulations
promulgated thereunder and that has not been disclosed in the
relevant Tax Return of the Company, or relevant
Subsidiary.
(f) Each of the Company and its
Subsidiaries has made available to Parent or its employees,
consultants, agents, advisors, affiliates or other representatives
all material ruling requests, private letter rulings, notices of
proposed deficiencies, closing agreements, settlement agreements,
and similar documents sent to or received by the Company or any of
its Subsidiaries on or after January 1, 2002, relating to any
material Taxes.
(g) There are no outstanding
agreements extending or waiving the statutory period of limitations
applicable to any claim for, or the period for the collection,
assessment or reassessment of any material Taxes due from the
Company or any of its Subsidiaries for any taxable period and, to
the Company’s Knowledge, no request for any such waiver or
extension is currently pending.
-24-
Section 4.14 ERISA
.
(a) With respect to each Employee
Benefit Plan, including multiemployer plans within the meaning of
ERISA Section 3(37) and all stock purchase, stock option,
severance, employment, change-in-control, fringe benefit,
collective bargaining, bonus, incentive, deferred compensation and
other material employee benefit plans, agreements, programs,
policies or other arrangements, whether or not subject to ERISA,
whether formal or informal, under which any Company Employee has
any present or future right to benefits, or which is maintained or
contributed to by the Company or any of its Subsidiaries, or under
which the Company or any of its Subsidiaries otherwise has any
present or future liability (the “ Company Benefit
Plans ”), individually and in the aggregate, no event has
occurred and, to the Knowledge of the Company, there exists no
condition or set of circumstances, in connection with which the
Company or any of its Subsidiaries could be subject to any
liability that would reasonably be expected to have, individually
or in the aggregate, a Material Adverse Effect on the Company under
ERISA, the Code or any other applicable Law and no nonexempt
“prohibited transaction” (as such term is defined in
Section 406 of ERISA and Section 4975 of the Code) or
“accumulated funding deficiency” (as such term is
defined in Section 302 of ERISA and Section 412 of the
Code (whether or not waived)) has occurred with respect to any
Company Benefit Plan which would reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect on the
Company. Any Company Benefit Plan that is intended to be qualified
under Section 401(a) of the Code has received a favorable
determination letter from the IRS or is reasonably expected to
receive a favorable determination letter from the IRS covering all
of the material provisions applicable to the Company Benefit Plan
for which determination letters are currently available that the
Company Benefit Plan is so qualified. With respect to each Company
Benefit Plan that is subject to Title IV or Section 302 of
ERISA or Section 412 or 4971 of the Code, as of the date
hereof: (i) no reportable event within the meaning of
Section 4043(c) of ERISA for which the 30-day notice
requirement has not been waived has occurred in the past six years;
(ii) all premiums to the Pension Benefit Guaranty Corporation
(the “ PBGC ”) have been timely paid in full;
(iii) no material liability (other than for premiums to the
PBGC) under Title IV of ERISA has been or is expected to